Improving Transition of Investigational Medicines in Alzheimer’s Disease From Phase I To Phase II
Improving Transition of Investigational Medicines in Alzheimer’s Disease From Phase I To Phase II
In January 2012, the Obama administration’s Presidential advisory g...